Deutsch English Français

Contact

EP1390012

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP1390012

EP1390012 - NOVEL METHODS AND COMPOSITIONS FOR DELIVERING MACROMOLECULES TO OR VIA THE RESPIRATORY TRACT [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 26.11.2010 Database last updated on 19.07.2024
Most recent event Tooltip	26.11.2010	Application deemed to be withdrawn	published on 29.12.2010 [2010/52]
Applicant(s)	For all designated states Novartis AG Lichtstrasse 35 4002 Basel / CH
	[N/P]
Former [2009/32]	For all designated states NOVARTIS AG Lichtstrasse 35 4002 Basel / CH
Former [2004/09]	For all designated states Nektar Therapeutics 150 Industrial Road San Carlos, CA 94070 / US
Inventor(s)	01 / BOT, Adrian 3899 Nobel Drive, Apt. 1117 San Diego, CA 92122 / US
	02 / DELLAMARY, Luis, A. 838 Redberry Court San Marcos, CA 92069-1846 / US
	03 / SMITH, Dan 4004 Caminito Meliado San Diego, CA 92122 / US
	[2004/09]
Representative(s)	Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstrasse 3 81675 München / DE
	[N/P]
Former [2008/35]	Vossius & Partner Siebertstrasse 3 81675 München / DE
Former [2004/09]	VOSSIUS & PARTNER Siebertstrasse 4 81675 München / DE
Application number, filing date	02728994.1	26.04.2002
	[2004/09]
	WO2002US13145
Priority number, date	US20010286891P	26.04.2001 Original published format: US 286891 P
	[2004/09]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO02087542
	Date:	07.11.2002
	Language:	EN
	[2002/45]
	Type:	A1 Application with search report
	No.:	EP1390012
	Date:	25.02.2004
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 07.11.2002 takes the place of the publication of the European patent application.
	[2004/09]
Search report(s)	International search report - published on:	US	07.11.2002
	(Supplementary) European search report - dispatched on:	EP	28.09.2009
Classification	IPC:	A61K9/127, A61K9/12, A61K9/14, A61K9/16, A61K9/50, A61K9/52	[2004/09]
	CPC:	A61K9/0075 (EP); B82Y5/00 (EP); A61K9/1075 (EP); A61K9/127 (EP); A61K9/1617 (EP)
Designated contracting states	AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2004/09]
Extension states	AL	26.11.2003
	LT	26.11.2003
	LV	26.11.2003
	MK	26.11.2003
	RO	26.11.2003
	SI	26.11.2003
Title	German:	NEUE VERFAHREN UND ZUSAMMENSETZUNGEN ZUR FREISETZUNG VON MAKROMOLEKÜLEN AN DIE ODER ÜBER DIE ATEMWEGE	[2004/09]
	English:	NOVEL METHODS AND COMPOSITIONS FOR DELIVERING MACROMOLECULES TO OR VIA THE RESPIRATORY TRACT	[2004/09]
	French:	NOUVELLES METHODES ET COMPOSITIONS D'ADMINISTRATION DE MACROMOLECULES AUX VOIES RESPIRATOIRES OU VIA CELLES-CI	[2004/09]
Entry into regional phase	26.11.2003	National basic fee paid
	26.11.2003	Search fee paid
	26.11.2003	Designation fee(s) paid
	26.11.2003	Examination fee paid
Examination procedure	15.11.2002	Request for preliminary examination filed International Preliminary Examining Authority: US
	26.11.2003	Amendment by applicant (claims and/or description)
	26.11.2003	Examination requested [2004/09]
	22.02.2010	Despatch of a communication from the examining division (Time limit: M04)
	06.07.2010	Application deemed to be withdrawn, date of legal effect [2010/52]
	11.08.2010	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2010/52]
Fees paid	Renewal fee
	15.04.2004	Renewal fee patent year 03
	13.04.2005	Renewal fee patent year 04
	27.03.2006	Renewal fee patent year 05
	10.04.2007	Renewal fee patent year 06
	18.03.2008	Renewal fee patent year 07
	16.04.2009	Renewal fee patent year 08
	25.03.2010	Renewal fee patent year 09
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[X]WO9619197 (ASTRA AB [SE], et al) [X] 9,10,31,33,34 * page 1, line 3 - line 4 * * page 2, line 11 - line 24 * * page 3, line 18 - line 19 * * examples 1h,1n,3h,3n * * claims 1,10-12,15,16,18-26,30,32,33,43-46 *;
		[X]WO9831346 (MASSACHUSETTS INST TECHNOLOGY [US], et al) [X] 1-9,11,12,16-30,32 * page 4, line 13 - page 6, line 23 * * page 11, line 12 - line 16 * * page 11, line 23 - page 13, line 2 * * page 22, line 13 - page 23, line 6 * * examples 3-14 * * claims 1-7,10-22,24-26,28-34,36 *;
		[DX]WO9916421 (ALLIANCE PHARMA [US], et al) [DX] 1-34 * the whole document * * page 4, line 3 - page 8, line 29 * * page 17, line 1 - page 19, line 17 * * page 21, line 27 - line 33 * * page 25, line 19 - line 27 * * examples 3-8,10-12,15-17 * * claims 1,5-8,10-20,22-26,36-55 *;
		[DX]WO9916422 (ALLIANCE PHARMA [US], et al) [DX] 1-34 * the whole document * * page 1, line 4 - line 8 * * page 3, line 21 - page 7, line 30 * * page 17, line 16 - page 18, line 4 * * page 18, line 19 - page 19, line 34 * * page 22, line 8 - line 14 * * page 26, line 5 - line 13 * * examples 3-7,9-16,18 * * claims 1-51 *;
		[X]WO0000215 (ALLIANCE PHARMA [US], et al) [X] 1-34 * the whole document * * page 3, line 26 - page 7, line 10 * * page 10, line 32 - page 11, line 6 * * page 21, line 19 - page 24, line 25 * * page 38, line 6 - line 14 * * page 40, line 9 - line 17 * * examples 1-22 * * claims 1-50 *;
		[PX]WO0185136 (ALLIANCE PHARMA [US]) [PX] 1-9,11-19,21-29,32 * the whole document * * page 4, line 1 - line 36 * * page 6, line 17 - page 7, line 4 * * page 8, line 1 - page 9, line 19 * * page 11, line 33 - page 12, line 2 * * page 12, line 18 - page 14, line 28 * * page 18, line 3 - line 14 * * examples 5,9,11,14-16 * * tables 4,5,10 * * claims 1-51 *;
		[PX]WO0185137 (ALLIANCE PHARMA [US], et al) [PX] 1-9,11,12,16,18,19,21-29,32 * the whole document * * page 5, line 12 - page 10, line 13 * * examples 11,15 * * claims 1-45 *;
		[X] - DELLAMARY L A ET AL, "HOLLOW POROUS PARTICLES IN METERED DOSE INHALERS", PHARMACEUTICAL RESEARCH, KLUWER ACADEMIC PUBLISHERS, NEW YORK, NY, US, (20000201), vol. 17, no. 2, ISSN 0724-8741, pages 168 - 174, XP009034216 [X] 1-9,11,12,16-18,21-28,32 * the whole document * * page 169, column L, line 25 - line 35 * * page 169, column L, line 47 - column R, line 9 * DOI: http://dx.doi.org/10.1023/A:1007513213292
	International search	[X]WO8801862 ;
		[X]US5985309

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 35p